Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.38 EUR | -0.59% | -4.84% | +36.25% |
Sales 2024 * | 3.3M 3.55M | Sales 2025 * | 2.15M 2.32M | Capitalization | 842M 907M |
---|---|---|---|---|---|
Net income 2024 * | -159M -171M | Net income 2025 * | -173M -186M | EV / Sales 2024 * | 229 x |
Net cash position 2024 * | 87.4M 94.12M | Net cash position 2025 * | 44.68M 48.11M | EV / Sales 2025 * | 370 x |
P/E ratio 2024 * |
-4.85
x | P/E ratio 2025 * |
-4.73
x | Employees | 61 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.25% |
Latest transcript on Abivax
1 day | -0.59% | ||
1 week | -4.84% | ||
Current month | -9.35% | ||
1 month | -0.74% | ||
3 months | +14.36% | ||
6 months | +40.84% | ||
Current year | +36.25% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 23-05-04 | |
Didier Blondel
DFI | Director of Finance/CFO | - | 17-01-01 |
Sheldon Sloan
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 13-12-03 | |
Kinam Hong
BRD | Director/Board Member | - | - |
Troy Ignelzi
BRD | Director/Board Member | 56 | 23-07-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 13.38 | -0.59% | 32,433 |
24-05-09 | 13.46 | 0.00% | 21,180 |
24-05-08 | 13.46 | -3.99% | 45,254 |
24-05-07 | 14.02 | +0.72% | 16,880 |
24-05-06 | 13.92 | -1.00% | 18,767 |
Real-time Euronext Paris, May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.25% | 907M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ABVX Stock